| Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis RM Neer, CD Arnaud, JR Zanchetta, R Prince, GA Gaich, JY Reginster, ... New England journal of medicine 344 (19), 1434-1441, 2001 | 5834 | 2001 |
| Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis DM Black, PD Delmas, R Eastell, IR Reid, S Boonen, JA Cauley, ... New England Journal of Medicine 356 (18), 1809-1822, 2007 | 3881 | 2007 |
| Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial ST Harris, NB Watts, HK Genant, CD McKeever, T Hangartner, M Keller, ... Jama 282 (14), 1344-1352, 1999 | 3250 | 1999 |
| Zoledronic acid and clinical fractures and mortality after hip fracture KW Lyles, CS Colón-Emeric, JS Magaziner, JD Adachi, CF Pieper, ... New England Journal of Medicine 357 (18), 1799-1809, 2007 | 2503 | 2007 |
| Evidence of estrogen receptors in normal human osteoblast-like cells EF Eriksen, DS Colvard, NJ Berg, ML Graham, KG Mann, TC Spelsberg, ... Science 241 (4861), 84-86, 1988 | 1679 | 1988 |
| Cellular mechanisms of bone remodeling EF Eriksen Reviews in Endocrine and Metabolic Disorders 11, 219-227, 2010 | 971 | 2010 |
| Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease EF Eriksen Endocrine reviews 7 (4), 379-408, 1986 | 776 | 1986 |
| Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited H Glerup, K Mikkelsen, L Poulsen, E Hass, S Overbeck, J Thomsen, ... Journal of internal medicine 247 (2), 260-268, 2000 | 759 | 2000 |
| Recombinant human parathyroid hormone (1–34)[teriparatide] improves both cortical and cancellous bone structure Y Jiang, JJ Zhao, BH Mitlak, O Wang, HK Genant, EF Eriksen Journal of bone and mineral research 18 (11), 1932-1941, 2003 | 711 | 2003 |
| Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement H Glerup, K Mikkelsen, L Poulsen, E Hass, S Overbeck, H Andersen, ... Calcified tissue international 66, 419-424, 2000 | 704 | 2000 |
| Effects of thyroid hormones on bone and mineral metabolism L Mosekilde, EF Eriksen, P Charles Endocrinology and metabolism clinics of North America 19 (1), 35-63, 1990 | 626 | 1990 |
| Identification of androgen receptors in normal human osteoblast-like cells. DS Colvard, EF Eriksen, PE Keeting, EM Wilson, DB Lubahn, FS French, ... Proceedings of the National Academy of Sciences 86 (3), 854-857, 1989 | 595 | 1989 |
| Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry EF Eriksen, P Charles, F Melsen, L Mosekilde, L Risteli, J Risteli Journal of bone and mineral research 8 (2), 127-132, 1993 | 533 | 1993 |
| Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers EM Hauge, D Qvesel, EF Eriksen, L Mosekilde, F Melsen Journal of bone and mineral research 16 (9), 1575-1582, 2001 | 526 | 2001 |
| Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass MR McClung, J San Martin, PD Miller, R Civitelli, F Bandeira, M Omizo, ... Archives of internal medicine 165 (15), 1762-1768, 2005 | 466 | 2005 |
| Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS E Tsourdi, B Langdahl, M Cohen-Solal, B Aubry-Rozier, EF Eriksen, ... Bone 105, 11-17, 2017 | 452 | 2017 |
| Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels EF Eriksen, SF Hodgson, R Eastell, BL RIGGS, SL Cedel, WM O'Fallon Journal of Bone and Mineral Research 5 (4), 311-319, 1990 | 440 | 1990 |
| Bone histomorphometry EF Eriksen, DW Axelrod, F Melsen (No Title), 1994 | 414 | 1994 |
| Fracture risk and zoledronic acid therapy in men with osteoporosis S Boonen, JY Reginster, JM Kaufman, K Lippuner, J Zanchetta, ... New England Journal of Medicine 367 (18), 1714-1723, 2012 | 408 | 2012 |
| Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH (1–34)] in postmenopausal osteoporosis F Cosman, EF Eriksen, C Recknor, PD Miller, N Guañabens, C Kasperk, ... Journal of Bone and Mineral Research 26 (3), 503-511, 2011 | 390 | 2011 |
